We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeut... Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. Show more
Halozyme to Report First Quarter 2024 Financial and Operating Results PR Newswire SAN DIEGO, April 23, 2024 SAN DIEGO, April 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO...
Halozyme to Participate in Upcoming Investor Conferences PR Newswire SAN DIEGO, Feb. 27, 2024 SAN DIEGO, Feb. 27, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.59 | 1.53846153846 | 38.35 | 39.42 | 37.73 | 790550 | 38.32553004 | CS |
4 | -1.63 | -4.01774710377 | 40.57 | 41.6 | 37.73 | 885391 | 39.58974259 | CS |
12 | 4.68 | 13.6602451839 | 34.26 | 42.64 | 33.15 | 1047257 | 38.74360333 | CS |
26 | 3.94 | 11.2571428571 | 35 | 42.82 | 32.83 | 1170636 | 37.57539971 | CS |
52 | 4.67 | 13.6270790779 | 34.27 | 45 | 29.85 | 1096459 | 37.45291723 | CS |
156 | -10.73 | -21.6025770083 | 49.67 | 59.46 | 29.85 | 1101114 | 41.14867752 | CS |
260 | 22.85 | 142.013673089 | 16.09 | 59.46 | 12.71 | 1197794 | 34.75157035 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions